S
IMVT icon

SignatureFD’s Immunovant IMVT Stock Holding History

SignatureFD’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Sell
2,816
-3
-0.1% -$91 ﹤0.01% 1400
2026
Q1 		$70K Hold
2,819
– – ﹤0.01% 1528
2025
Q4 		$71.7K Buy
2,819
+320
+13% +$7.14K ﹤0.01% 1468
2025
Q3 		$40.3K Buy
2,499
+2,074
+488% +$33.6K ﹤0.01% 1753
2025
Q2 		$6.8K Sell
425
-407
-49% -$6.16K ﹤0.01% 2489
2025
Q1 		$14.2K Buy
832
+466
+127% +$9.75K ﹤0.01% 2222
2024
Q4 		$9.07K Buy
366
+80
+28% +$2.27K ﹤0.01% 2399
2024
Q3 		$8.15K Buy
286
+4
+1% +$118 ﹤0.01% 2415
2024
Q2 		$7.45K Hold
282
– – ﹤0.01% 2380
2024
Q1 		$9.11K Sell
282
-27
-9% -$985 ﹤0.01% 2329
2023
Q4 		$13K Buy
309
+27
+10% +$994 ﹤0.01% 2138
2023
Q3 		$10.8K Buy
282
+146
+107% +$3.3K ﹤0.01% 2172
2023
Q2 		$2.58K Hold
136
– – ﹤0.01% 2733
2023
Q1 		$2.11K Buy
136
+8
+6% +$139 ﹤0.01% 2792
2022
Q4 		$2.27K Buy
+128
New +$1.61K ﹤0.01% 2769
2022
Q1 		– Sell
-840
Closed -$7K – 3225
2021
Q4 		$7K Sell
840
-960
-53% -$7.92K ﹤0.01% 2267
2021
Q3 		$16K Buy
1,800
+300
+20% +$2.71K ﹤0.01% 1859
2021
Q2 		$16K Hold
1,500
– – ﹤0.01% 1806
2021
Q1 		$24K Hold
1,500
– – ﹤0.01% 1505
2020
Q4 		$69K Sell
1,500
-2,000
-57% -$92.5K ﹤0.01% 934
2020
Q3 		$123K Sell
3,500
-1,500
-30% -$45.1K 0.01% 638
2020
Q2 		$122K Buy
5,000
+1,500
+43% +$32.1K 0.01% 620
2020
Q1 		$54K Buy
+3,500
New +$52.7K ﹤0.01% 860

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SignatureFD's IMVT Position: Q2 2026 in Review

SignatureFD reduced its Immunovant (IMVT) stake by 0.11% in Q2 2026, selling an estimated $91 and leaving 2,816 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

SignatureFD first reported a position in IMVT in Q1 2020 and has held it in 23 quarters since. The position peaked at $123K in Q3 2020. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • SignatureFD held 2,816 shares of Immunovant worth $109K as of Q2 2026.
  • SignatureFD sold 3 Immunovant shares in Q2 2026, an estimated $91.
  • Immunovant made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1400 holding.
  • SignatureFD first reported a position in Immunovant in Q1 2020 and has held it in 23 quarters since.
  • SignatureFD's Immunovant position peaked at $123K in Q3 2020.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.